Matches in SemOpenAlex for { <https://semopenalex.org/work/W2024663693> ?p ?o ?g. }
Showing items 1 to 83 of
83
with 100 items per page.
- W2024663693 endingPage "389" @default.
- W2024663693 startingPage "384" @default.
- W2024663693 abstract "In a longitudinal study, antiasthmatic and metabolic effects of budesonide inhalations in initially high (800 micrograms/m2/day for 1 month) and subsequently lower (400 micrograms/m2/day for 4 months) dosage were evaluated in nine children with asthma, aged 5 to 10 years. The FEV1 increased significantly after high dosage (median, 96.5% versus 105.5%; p = 0.0339). After lower dosage, FEV1 was still higher than at the baseline (106% versus 96.5%; p = 0.0339). Clinically, no additional beta2-agonist was needed after 2 weeks of treatment. Serum high-density lipoprotein cholesterol increased significantly by 22% after high dosage (medians, 1.18 versus 1.44 mmol/L). A significant decline to 1.31 mmol/L was observed when the dose was reduced (overall, p = 0.0319). The treatment had no significant effect on serum total cholesterol, on serum triglycerides, on the ratio of high-density lipoprotein to total cholesterol, on the body mass index, or on glucose tolerance. The high dosage increased significantly the ratio of serum insulin to blood glucose, calculated from the areas under the incremental 2-hour curves in the glucose tolerance test (medians, 17.3 versus 23.2 mU/mmol). After lower dosage, the ratio declined significantly to 13.5 mU/mmol (overall, p = 0.0164). No significant changes were observed in plasma cortisol in the 2-hour adrenocorticotropic hormone test. The antiasthmatic effect of budesonide inhalations in a dose of 800 micrograms/m2/day for 1 month was accompanied by detectable changes in lipid and carbohydrate metabolism. These metabolic changes were reversible, and the antiasthmatic effect could be maintained by a dose of 400 micrograms/m2 for 4 months without significant systemic effects. This dose is safe and efficient in the maintenance treatment of childhood asthma." @default.
- W2024663693 created "2016-06-24" @default.
- W2024663693 creator A5016891667 @default.
- W2024663693 creator A5039526948 @default.
- W2024663693 creator A5040300144 @default.
- W2024663693 date "1991-09-01" @default.
- W2024663693 modified "2023-09-25" @default.
- W2024663693 title "Changes in carbohydrate and lipid metabolism in children with asthma inhaling budesonide" @default.
- W2024663693 cites W1965343609 @default.
- W2024663693 cites W1984440331 @default.
- W2024663693 cites W2011173327 @default.
- W2024663693 cites W2013028382 @default.
- W2024663693 cites W2015625185 @default.
- W2024663693 cites W2031111440 @default.
- W2024663693 cites W2031358020 @default.
- W2024663693 cites W2048632222 @default.
- W2024663693 cites W2066830667 @default.
- W2024663693 cites W2075020124 @default.
- W2024663693 cites W2090383821 @default.
- W2024663693 cites W2112675494 @default.
- W2024663693 cites W2119186903 @default.
- W2024663693 cites W2119990339 @default.
- W2024663693 cites W2143171523 @default.
- W2024663693 cites W2155479569 @default.
- W2024663693 cites W2157219243 @default.
- W2024663693 doi "https://doi.org/10.1016/0091-6749(91)90101-s" @default.
- W2024663693 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/1890267" @default.
- W2024663693 hasPublicationYear "1991" @default.
- W2024663693 type Work @default.
- W2024663693 sameAs 2024663693 @default.
- W2024663693 citedByCount "56" @default.
- W2024663693 countsByYear W20246636932012 @default.
- W2024663693 countsByYear W20246636932013 @default.
- W2024663693 countsByYear W20246636932015 @default.
- W2024663693 countsByYear W20246636932016 @default.
- W2024663693 countsByYear W20246636932020 @default.
- W2024663693 countsByYear W20246636932021 @default.
- W2024663693 countsByYear W20246636932022 @default.
- W2024663693 countsByYear W20246636932023 @default.
- W2024663693 crossrefType "journal-article" @default.
- W2024663693 hasAuthorship W2024663693A5016891667 @default.
- W2024663693 hasAuthorship W2024663693A5039526948 @default.
- W2024663693 hasAuthorship W2024663693A5040300144 @default.
- W2024663693 hasConcept C126322002 @default.
- W2024663693 hasConcept C134018914 @default.
- W2024663693 hasConcept C17093226 @default.
- W2024663693 hasConcept C185592680 @default.
- W2024663693 hasConcept C2776042228 @default.
- W2024663693 hasConcept C2776136866 @default.
- W2024663693 hasConcept C2778163477 @default.
- W2024663693 hasConcept C2778977261 @default.
- W2024663693 hasConcept C71924100 @default.
- W2024663693 hasConceptScore W2024663693C126322002 @default.
- W2024663693 hasConceptScore W2024663693C134018914 @default.
- W2024663693 hasConceptScore W2024663693C17093226 @default.
- W2024663693 hasConceptScore W2024663693C185592680 @default.
- W2024663693 hasConceptScore W2024663693C2776042228 @default.
- W2024663693 hasConceptScore W2024663693C2776136866 @default.
- W2024663693 hasConceptScore W2024663693C2778163477 @default.
- W2024663693 hasConceptScore W2024663693C2778977261 @default.
- W2024663693 hasConceptScore W2024663693C71924100 @default.
- W2024663693 hasIssue "3" @default.
- W2024663693 hasLocation W20246636931 @default.
- W2024663693 hasLocation W20246636932 @default.
- W2024663693 hasOpenAccess W2024663693 @default.
- W2024663693 hasPrimaryLocation W20246636931 @default.
- W2024663693 hasRelatedWork W1981942942 @default.
- W2024663693 hasRelatedWork W2003811568 @default.
- W2024663693 hasRelatedWork W2035331946 @default.
- W2024663693 hasRelatedWork W2054690921 @default.
- W2024663693 hasRelatedWork W2063441939 @default.
- W2024663693 hasRelatedWork W2082995727 @default.
- W2024663693 hasRelatedWork W2105661387 @default.
- W2024663693 hasRelatedWork W2284164753 @default.
- W2024663693 hasRelatedWork W2436515053 @default.
- W2024663693 hasRelatedWork W2748952813 @default.
- W2024663693 hasVolume "88" @default.
- W2024663693 isParatext "false" @default.
- W2024663693 isRetracted "false" @default.
- W2024663693 magId "2024663693" @default.
- W2024663693 workType "article" @default.